Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.47% | 131.02 | 0.0% | $2314.17m | |
| BNGO | BioNano Genomics, Inc. | 18.50% | 9.80 | 0.0% | $2016.46m | |
| GILD | Gilead Sciences, Inc. | -0.06% | 66.94 | 1.0% | $649.72m | |
| AMGN | Amgen, Inc. | 0.58% | 253.50 | 1.3% | $564.60m | |
| CRSP | CRISPR Therapeutics AG | 1.83% | 188.49 | 0.6% | $487.99m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.43% | 537.78 | 2.7% | $478.09m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.19% | 159.73 | 2.0% | $470.59m | |
| NVAX | Novavax, Inc. | 3.74% | 126.98 | 92.9% | $417.43m | |
| ILMN | Illumina, Inc. | 0.34% | 406.25 | 3.5% | $396.72m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.36% | 98.24 | 13.8% | $364.79m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.44% | 237.59 | 1.9% | $361.85m | |
| BIIB | Biogen, Inc. | -0.25% | 269.44 | 1.7% | $321.90m | |
| BNTX | BioNTech SE | 2.86% | 108.44 | 0.0% | $298.33m | |
| EXAS | EXACT Sciences Corp. | 1.30% | 150.00 | 19.6% | $243.95m | |
| PACB | Pacific Biosciences of California, Inc. | 3.06% | 37.42 | 7.4% | $228.17m |
Company Profile
Novavax, Inc. is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. The firm's vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.